These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37482925)

  • 1. In vitro μ-opioid receptor activation potential of U10 and β-U10, positional isomers of the synthetic opioid naphthyl U-47700.
    Vandeputte MM; Stove CP
    Drug Test Anal; 2024 Mar; 16(3):323-326. PubMed ID: 37482925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.
    Vandeputte MM; Persson M; Walther D; Vikingsson S; Kronstrand R; Baumann MH; Gréen H; Stove CP
    Arch Toxicol; 2022 Mar; 96(3):877-897. PubMed ID: 35072756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
    Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
    Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs.
    Vandeputte MM; Walton SE; Shuda SA; Papsun DM; Krotulski AJ; Stove CP
    Anal Bioanal Chem; 2023 Sep; 415(21):5165-5180. PubMed ID: 37173408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
    Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.
    Vandeputte MM; Verougstraete N; Walther D; Glatfelter GC; Malfliet J; Baumann MH; Verstraete AG; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1865-1880. PubMed ID: 35449307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case study: Identification and characterization of N-[2-(dimethylamino)cyclohexyl]-N-methylnaphthalene-2-carboxamide, a regioisomer of the synthetic opioid U10.
    Collins M; Brown D; Davies S; Chan B; Trotter B; Moawad M; Blakey K; Collins-Brown L
    Drug Test Anal; 2022 Jan; 14(1):188-195. PubMed ID: 34390197
    [No Abstract]   [Full Text] [Related]  

  • 9. Are the N-demethylated metabolites of U-47700 more active than their parent compound? In vitro μ-opioid receptor activation of N-desmethyl-U-47700 and N,N-bisdesmethyl-U-47700.
    Nordmeier F; Cannaert A; Stove CP; Schmidt PH; Meyer MR; Schaefer N
    Drug Test Anal; 2022 Apr; 14(4):713-717. PubMed ID: 34669261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the μ- and κ-opioid receptor activation by eight new synthetic opioids using the [
    Otte L; Wilde M; Auwärter V; Grafinger KE
    Drug Test Anal; 2022 Jul; 14(7):1187-1199. PubMed ID: 35142070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
    Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
    Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl.
    Xie B; Le Rouzic VP; Goldberg A; Tsai MM; Chen L; Zhang T; Sinha A; Pan YX; Baumann MH; Shi L
    Neuropharmacology; 2023 Apr; 227():109442. PubMed ID: 36731721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of N-desethyl etonitazene in a drug checking sample: Chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole "nitazene" class.
    Monti MC; De Vrieze LM; Vandeputte MM; Persson M; Gréen H; Stove CP; Schlotterbeck G
    J Pharm Biomed Anal; 2024 Dec; 251():116453. PubMed ID: 39216307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization.
    Vandeputte MM; Bilel S; Tirri M; Corli G; Bassi M; Layle NK; Fantinati A; Walther D; Iula DM; Baumann MH; Stove CP; Marti M
    Neuropharmacology; 2024 Dec; 260():110113. PubMed ID: 39154855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace residue identification, characterization, and longitudinal monitoring of the novel synthetic opioid β-U10, from discarded drug paraphernalia.
    West H; Fitzgerald JL; Hopkins KL; Leeming MG; DiRago M; Gerostamoulos D; Clark N; Dietze P; White JM; Ziogas J; Reid GE
    Drug Test Anal; 2022 Sep; 14(9):1576-1586. PubMed ID: 35562123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238.
    Fogarty MF; Vandeputte MM; Krotulski AJ; Papsun D; Walton SE; Stove CP; Logan BK
    Arch Toxicol; 2022 Jun; 96(6):1701-1710. PubMed ID: 35275255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market.
    Baumann MH; Tocco G; Papsun DM; Mohr AL; Fogarty MF; Krotulski AJ
    Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33238449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico characterization of ligand-receptor interactions for U-47700, N,N-didesmethyl-U-47700, U-50488 at mu- and kappa-opioid receptors.
    Laus A; Kumar A; Caboni P; De Luca MA; Baumann MH; Pieroni E; Tocco G
    Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300256. PubMed ID: 37452407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
    Baumann MH; Majumdar S; Le Rouzic V; Hunkele A; Uprety R; Huang XP; Xu J; Roth BL; Pan YX; Pasternak GW
    Neuropharmacology; 2018 May; 134(Pt A):101-107. PubMed ID: 28807672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.
    Mohr AL; Friscia M; Papsun D; Kacinko SL; Buzby D; Logan BK
    J Anal Toxicol; 2016 Nov; 40(9):709-717. PubMed ID: 27590036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.